During the past decade, Synexus Polska Sp. z o.o. Oddzial w Katowicach conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 25 clinical trials were completed, i.e. on average, 65.8% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 19 clinical trials were completed. i.e. 95% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Polska Sp. z o.o. Oddzial w Katowicach" #1 sponsor was "Pfizer" with 9 trials, followed by "Incyte Corporation" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Polska Sp. z o.o. Oddzial w Katowicach" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Synexus Polska Sp. z o.o. Oddzial w Katowicach" are "Crohn's Disease" (4 trials), "Psoriasis" (4 trials), "Cardiovascular Disease" (2 trials), "Chronic Rhinosinusitis" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Synexus Polska Sp. z o.o. Oddzial w Katowicach" in a lesser frequency.

Most popular intervention types in "Synexus Polska Sp. z o.o. Oddzial w Katowicach" are "Drug" (37 trials), "Biological" (5 trials), "Other" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "BMS-986165" (2 trials), "CC-93538" (2 trials), "CHS-0214" (2 trials) and "Etanercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Polska Sp. z o.o. Oddzial w Katowicach" are 41 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Synexus Polska Sp. z o.o. Oddzial w Katowicach". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Synexus Polska Sp. z o.o. Oddzial w Katowicach, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Polska Sp. z o.o. Oddzial w Katowicach, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".